Company Overview
Snapshot
Founded in April 2020 by Noam Levine, FIZE Medical operates with 11–50 employees. The company has raised $45.87 million across 7 funding rounds from 6 investors. In March 2026, FIZE Medical announced a $6 million warrant exercise, bringing its total Series A financing to $36 million.
Business overview
FIZE Medical develops a platform technology for the remote monitoring and management of patients with indwelling Foley catheters. Its core product, the FIZE kUO device, provides digital real-time measurement of kidney urine output and other key health indicators from urine, delivering customized alerts for evidence-based clinical decision-making. The company's FDA-registered device has undergone clinical trials for efficacy and safety, serving the healthcare industry by enhancing fluid management for critically ill patients.
Strategic signal
In December 2025, FIZE Medical announced an exclusive distribution agreement with Asahi Kasei Medical to launch its FIZE kUO system in Japan. This strategic partnership signals a significant global expansion for FIZE Medical, leveraging Asahi Kasei Medical's leadership in blood treatment technologies to integrate digital kidney data into critical care settings, thereby improving patient outcomes and accelerating market penetration in Asia.
Log in to access full profile ›Company Intelligence Q&A
- What was the most recent funding event for FIZE Medical?
- In March 2026, FIZE Medical announced a $6 million warrant exercise, which increased its total Series A financing to $36 million.
- What strategic partnership did FIZE Medical recently establish in Japan?
- In December 2025, FIZE Medical signed an exclusive distribution agreement with Asahi Kasei Medical to launch its FIZE kUO system in Japan, aiming to enhance fluid management for critically ill patients.
- Which investors participated in FIZE Medical's Series A funding round in December 2024?
- In December 2024, FIZE Medical secured Series A funding from investors including.
- Did FIZE Medical receive any grants recently?
- In February 2024, FIZE Medical received a grant from the Israel Innovation Authority.
- What was the nature of FIZE Medical's partnership with Eldan in November 2025?
- In November 2025, FIZE Medical secured an investment and distribution partnership with Eldan, a Neopharm Group company, making Eldan the exclusive distributor of FIZE Medical's products in Israel.